Clinical Trials
78 trialsPSMA SRT
Jonsson Comprehensive Cancer Center
Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone
Emory University
Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer
Ohio State University Comprehensive Cancer Center
LORUP
Umeå University
Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy
City of Hope Medical Center
RECIPE-B1
Mayo Clinic
TulmiSTAR-01
Novartis
Cancer and Blood Pressure Management, CARISMA Study
Eastern Cooperative Oncology Group
A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men
Mayo Clinic
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer
University of Michigan Rogel Cancer Center
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
Thomas Jefferson University
A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer
Sunnybrook Health Sciences Centre
Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Swiss Cancer Institute
PLATON
Canadian Cancer Trials Group
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
City of Hope Medical Center
Access to Genetic Testing in Underserved Patients With Cancer
University of Southern California
EMPOWER
University of Washington
Telehealth Intervention for Ostomy Self-Management
City of Hope Medical Center
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
University of Washington
AcTFirst
Novartis
Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial
Mayo Clinic
The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only
Telix Pharmaceuticals (Innovations) Pty Limited
ID-COMET
Roswell Park Cancer Institute
Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy
University of Pittsburgh
Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study
Fred Hutchinson Cancer Center
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
City of Hope Medical Center
Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute
KP-CARAIBES
Centre Hospitalier Universitaire de la Guadeloupe
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer
M.D. Anderson Cancer Center
Testosterone Therapy in Castration Resistant Prostate Cancer
University of Colorado, Denver
HEAT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
IMAGINE
Memorial Sloan Kettering Cancer Center
Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC
Goethe University
IMPACT
Vanderbilt-Ingram Cancer Center
The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting
Västernorrland County Council, Sweden
BeSpoke
University College, London
ZMoveMent-1
Ludwig-Maximilians - University of Munich
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
ITALIC-RCC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Oligo-PRESTO
UNICANCER
PEACE 7
UNICANCER
A Digital Therapeutic Solution for Cancer Patients
Sidekick Health
IP2-ATLANTA
Imperial College London
Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer
Alliance for Clinical Trials in Oncology
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Stanford University
Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)
UNICANCER
Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy
Sir Mortimer B. Davis - Jewish General Hospital
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Cellvax Therapeutics Inc
Enhanced Recovery After Surgery (ERAS) for Ambulatory TURBT
Johns Hopkins University
COMRADE
Sheffield Teaching Hospitals NHS Foundation Trust